Bristol-Myers Squibb Co (BMY) Stock Gains 3.06% This Week: Is It a Good Pick?

Bristol-Myers Squibb Co (BMY) stock is down -37.40% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives BMY stock a score of 27 out of a possible 100.

That rank is influenced by a long-term technical score of 5. BMY's rank also includes a short-term technical score of 9.

BMY has an Overall Score of 27. Find out what this means to you and get the rest of the rankings on BMY!

See Full BMY Report

What's Happening with BMY Stock Today

Bristol-Myers Squibb Co (BMY) stock is up 0.83% while the S&P 500 is down -0.72% as of 9:56 AM on Monday, Dec 4. BMY is up $0.42 from the previous closing price of $50.10 on volume of 480,074 shares. Over the past year the S&P 500 has risen 14.07% while BMY is down -37.40%. BMY earned $3.94 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 12.77. Click Here to get the full Stock Report for Bristol-Myers Squibb Co stock.